Aino Health AB (publ) (STO:AINO)
Sweden · Delayed Price · Currency is SEK 0.1370
+0.0130 (10.48%)
Jun 5, 2026, 5:30 PM CET
Aino Health AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.81 | 5.81 | 0.74 | 1.44 | 2.16 | 0.45 |
Cash & Short-Term Investments | 3.81 | 5.81 | 0.74 | 1.44 | 2.16 | 0.45 |
Cash Growth | 252.82% | 683.54% | -48.36% | -33.50% | 376.38% | -94.97% |
Accounts Receivable | 2.62 | 1.11 | 3.08 | 3.31 | 3.39 | 2.78 |
Other Receivables | - | 0.4 | 0.48 | 0.39 | 0.44 | 0.93 |
Receivables | 2.62 | 1.51 | 3.55 | 3.7 | 3.83 | 3.7 |
Prepaid Expenses | - | 0.17 | 0.27 | 0.26 | 0.25 | 0.3 |
Total Current Assets | 6.44 | 7.48 | 4.56 | 5.39 | 6.24 | 4.46 |
Property, Plant & Equipment | 0.05 | 0.05 | 0.08 | 0.1 | 0.16 | 0.19 |
Goodwill | - | 1.42 | 3.51 | 5.33 | 7.29 | 8.48 |
Other Intangible Assets | 1.44 | 0.72 | 1.69 | 2.65 | 3.61 | 4.58 |
Other Long-Term Assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 1.31 |
Total Assets | 7.97 | 9.72 | 9.88 | 13.51 | 17.33 | 19.02 |
Accounts Payable | - | 2.3 | 1.63 | 1.6 | 1.76 | 1.85 |
Accrued Expenses | - | 1.97 | 2.21 | 1.69 | 1.97 | 2.45 |
Short-Term Debt | - | 0.54 | 0.17 | - | - | - |
Other Current Liabilities | 8.76 | 3.55 | 6.33 | 10.91 | 15.19 | 11.08 |
Total Current Liabilities | 8.76 | 8.36 | 10.34 | 14.2 | 18.91 | 15.38 |
Long-Term Debt | 7.87 | 7.78 | - | 0.16 | 0.66 | 1.06 |
Other Long-Term Liabilities | - | - | - | -0 | - | - |
Total Liabilities | 16.63 | 16.14 | 10.34 | 14.37 | 19.57 | 16.44 |
Common Stock | 3.85 | 3.85 | 3.85 | 1.59 | 0.8 | 0.51 |
Additional Paid-In Capital | 94.22 | 94.22 | 94.22 | 86.15 | 74.86 | 65.15 |
Retained Earnings | - | -6.11 | -9.92 | -10.66 | -14.96 | -15.22 |
Comprehensive Income & Other | -106.73 | -98.38 | -88.61 | -77.94 | -62.93 | -47.86 |
Shareholders' Equity | -8.66 | -6.42 | -0.46 | -0.85 | -2.23 | 2.58 |
Total Liabilities & Equity | 7.97 | 9.72 | 9.88 | 13.51 | 17.33 | 19.02 |
Total Debt | 7.87 | 8.32 | 0.17 | 0.16 | 0.66 | 1.06 |
Net Cash (Debt) | -4.06 | -2.52 | 0.57 | 1.27 | 1.5 | -0.61 |
Net Cash Growth | - | - | -55.07% | -15.21% | - | - |
Net Cash Per Share | -0.02 | -0.01 | 0.01 | 0.02 | 0.04 | -0.02 |
Filing Date Shares Outstanding | 204.57 | 204.57 | 204.57 | 84.57 | 42.29 | 26.9 |
Total Common Shares Outstanding | 204.57 | 204.57 | 204.57 | 84.57 | 42.29 | 26.9 |
Working Capital | -2.32 | -0.88 | -5.78 | -8.81 | -12.67 | -10.92 |
Book Value Per Share | -0.04 | -0.03 | -0.00 | -0.01 | -0.05 | 0.10 |
Tangible Book Value | -10.1 | -8.56 | -5.65 | -8.83 | -13.13 | -10.48 |
Tangible Book Value Per Share | -0.05 | -0.04 | -0.03 | -0.10 | -0.31 | -0.39 |
Machinery | - | 0.75 | 0.75 | 0.75 | 0.78 | 0.78 |